Atlas Trials

A Study of ARGX-110 in Participants With Advanced Malignancies

Clinical trial NCT01813539 · COMPLETED

Trial details

NCT number
NCT01813539
Sponsor
OncoVerity, Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neoplasms
Start date
2013-02-27
Primary completion
2020-07-10
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.